References
- Conn J. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955; 45: 3–17
- Young WF, Jr. Minireview: primary aldosteronism—changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 2208–2213
- Stowasser M, Gordon RD. Primary aldosteronism—careful investigation is essential and rewarding. Mol Cell Endocrinol 2004; 217: 33–39
- Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED, Jr., Sos TA, Atlas SA, Muller FB, Acevedo R, Ulick S, Laragh JH. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877–885
- Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227–1235
- Balkin PW, Hollifield JW, Winn SD, Shaff MI. Primary aldosteronism: computerized tomography in preoperative evaluation. South Med J 1985; 78: 1071–1073
- Rossi GP, Chiesura-Corona M, Tregnaghi A, Zanin L, Perale R, Soattin S, Pelizzo MR, Feltrin GP, Pessina AC. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens 1993; 7: 357–363
- Gross MD, Shapiro B, Freitas JE. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy. J Nucl Med 1985; 26: 43–48
- Ganguly A, Dowdy AJ, Luetscher JA, Melada GA. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 1973; 36: 401–404
- Fontes RG, Kater CE, Biglieri EG, Irony I. Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. Am J Hypertens 1991; 4: 786–791
- Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001; 37: 1440–1443
- Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill JR, Jr. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000; 85: 4526–4533
- Lebel M, Grose JH. Angiotensin II effect on plasma steroids in selective hypoaldosteronism. Horm Metab Res 1982; 14: 432–436
- Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med 1994; 13: 499–508
- Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045–1050
- Kater CE, Biglieri EG, Brust N, Chang B, Hirai J, Irony I. Stimulation and suppression of the mineralocorticoid hormones in normal subjects and adrenocortical disorders. Endocr Rev 1989; 10: 149–164
- Sheaves R, Goldin J, Reznek RH, Chew SL, Dacie JE, Lowe DG, Ross RJ, Wass JA, Besser GM, Grossman AB. Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. Eur J Endocrinol 1996; 134: 308–313
- Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 1987; 5: S103–S106
- Feltynowski T, Ignatowska-Switalska H, Wocial B, Lewandowski J, Chodakowska J, Januszewicz W. Postural stimulation test in patients with aldosterone producing adenomas. Clin Endocrinol (Oxf) 1994; 41: 309–314
- Irony I, Kater CE, Biglieri EG, Shackleton CH. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens 1990; 3: 576–582